Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | |
---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||||
Cash from operating activities | -129.55%-51.28M | 176.32%173.53M | -58.39%62.8M | -19.89%150.93M | 19.62%188.4M | 1.27%157.5M | 155.52M |
Net profit before non-cash adjustment | -136.05%-27.2M | -59.88%75.46M | 774.23%188.06M | 83.78%-27.89M | -362.71%-171.92M | 19.37%65.44M | --54.82M |
Total adjustment of non-cash items | 32.38%107.28M | -35.12%81.04M | -36.24%124.91M | -28.03%195.92M | 60.26%272.23M | 3.36%169.87M | --164.36M |
-Depreciation and amortization | -7.82%84.85M | -40.01%92.05M | 6.08%153.43M | -14.88%144.63M | 16.24%169.92M | -8.85%146.18M | --160.38M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | --58.2M | --0 | ---- |
-Disposal profit | 67.67%-3.72M | 67.64%-11.5M | -3,139.56%-35.54M | ---1.1M | ---- | -158.15%-3.13M | ---1.21M |
-Net exchange gains and losses | --0 | 61.41%-18.21M | -8,091.49%-47.18M | ---576K | ---- | ---- | ---- |
-Other non-cash items | 39.83%26.15M | -65.51%18.7M | 2.34%54.21M | 20.06%52.97M | 64.45%44.12M | 417.00%26.83M | --5.19M |
Changes in working capital | -870.79%-131.35M | 106.81%17.04M | -1,362.45%-250.17M | -119.42%-17.11M | 213.19%88.08M | -22.25%-77.82M | ---63.65M |
-Change in receivables | 200.68%12.07M | 93.14%-11.99M | -64.34%-174.86M | -139.76%-106.41M | 459.75%267.64M | 25.03%-74.4M | ---99.24M |
-Change in inventory | 80.45%-11.99M | 77.87%-61.35M | -649.15%-277.14M | -293.45%-36.99M | 157.68%19.12M | 61.01%-33.16M | ---85.03M |
-Change in payables | -398.26%-28.69M | 83.80%9.62M | -71.97%5.23M | 183.93%18.67M | -270.53%-22.25M | -88.58%13.05M | --114.21M |
-Change in accrued expense | 111.26%4.56M | -169.07%-40.48M | 1,051.87%58.61M | -75.19%5.09M | 317.27%20.51M | -572.14%-9.44M | --2M |
-Provision for loans, leases and other losses | -301.15%-3.51M | -21.34%1.74M | 2,408.33%2.22M | 99.71%-96K | -249.74%-33.35M | 405.20%22.27M | --4.41M |
-Changes in other current assets | -186.86%-103.79M | -12.00%119.49M | 32.30%135.78M | 162.73%102.63M | -4,339.41%-163.6M | --3.86M | ---- |
Dividends paid (cash flow from operating activities) | |||||||
Dividends received (cash flow from operating activities) | |||||||
Interest paid (cash flow from operating activities) | -33.37%-22.05M | 32.82%-16.53M | -5.00%-24.61M | -3.21%-23.44M | -21.14%-22.71M | -28.36%-18.75M | -14.61M |
Interest received (cash flow from operating activities) | 372.33%751K | -95.69%159K | 22.23%3.69M | -20.43%3.02M | 25.93%3.79M | 40.42%3.01M | 2.15M |
Tax refund paid | 145.27%97.53M | -19,976.70%-215.42M | 22.64%-1.07M | 92.33%-1.39M | 21.20%-18.08M | 11.33%-22.95M | -25.88M |
Other operating cash inflow (outflow) | -200.00%-1K | 1K | 0 | 0 | 0 | -1K | 0 |
Operating cash flow | 142.82%24.95M | -242.79%-58.26M | -68.40%40.81M | -14.72%129.12M | 27.42%151.39M | 1.39%118.82M | --117.18M |
Investing cash flow | |||||||
Net PPE purchase and sale | -278.62%-99.57M | 63.87%-26.3M | -17.57%-72.8M | 69.76%-61.92M | -34.93%-204.73M | 34.55%-151.74M | ---231.83M |
Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---- | -119.63%-6.75M | ---3.07M |
Net business purchase and sale | --0 | 282.47%700.88M | ---384.1M | --0 | ---- | ---- | ---- |
Net investment product transactions | --0 | 1,100.00%12M | --1M | ---- | ---- | ---- | ---- |
Net changes in other investments | -406.08%-8.9M | -102.80%-1.76M | 2,977.36%62.93M | 271.27%2.05M | -104.83%-1.19M | 163.57%24.72M | --9.38M |
Investing cash flow | -115.84%-108.48M | 274.27%684.82M | -556.32%-392.97M | 70.92%-59.87M | -53.94%-205.93M | 40.68%-133.77M | ---225.52M |
Financing cash flow | |||||||
Net issuance payments of debt | 146.19%268.14M | -2,620.15%-580.45M | 74.75%-21.34M | -256.27%-84.5M | -110.63%-23.72M | -8.91%223.22M | --245.07M |
Increase or decrease of lease financing | 21.48%-2.79M | 73.93%-3.56M | 1.86%-13.64M | -21.46%-13.9M | -247.53%-11.44M | ---3.29M | ---- |
Issuance fees | -52.93%-4.8M | 61.61%-3.14M | -175.11%-8.18M | 88.58%-2.97M | ---26.03M | --0 | ---- |
Cash dividends paid | 40.00%-9M | ---15M | ---- | ---- | 23.08%-4.5M | 31.58%-5.85M | ---8.55M |
Cash dividends for minorities | ---- | ---- | -13.43%-3.81M | 3.64%-3.36M | 5.94%-3.49M | -37.16%-3.71M | ---2.7M |
Net other fund-raising expenses | ---3K | ---- | -103.57%-3K | 101.11%84K | -140.86%-7.58M | 913.74%18.54M | ---2.28M |
Financing cash flow | 141.77%251.54M | -1,181.90%-602.15M | 55.12%-46.97M | -36.35%-104.65M | -133.53%-76.75M | -1.13%228.91M | --231.54M |
Net cash flow | |||||||
Beginning cash position | 57.81%76.54M | -87.94%48.5M | -7.49%402.23M | -23.97%434.8M | 51.81%571.89M | 53.29%376.72M | --245.75M |
Current changes in cash | 588.35%168.01M | 106.12%24.41M | -1,027.18%-399.14M | 73.03%-35.41M | -161.36%-131.28M | 73.67%213.96M | --123.2M |
Effect of exchange rate changes | 42.34%5.17M | -92.01%3.63M | 1,497.12%45.41M | 148.93%2.84M | 69.08%-5.81M | -341.83%-18.79M | --7.77M |
Cash adjustments other than cash changes | 300.00%2K | ---1K | ---- | ---- | -200.00%-1K | 0.00%1K | --1K |
End cash Position | 226.27%249.72M | 57.81%76.54M | -87.94%48.5M | -7.49%402.23M | -23.97%434.8M | 51.81%571.89M | --376.72M |
Free cash flow | -3.50%-88.92M | -168.51%-85.91M | -147.61%-31.99M | 225.98%67.2M | -20.41%-53.34M | 62.75%-44.3M | ---118.93M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |